This phenotype could correspond to antigen presenting cells-like hybrid tumour associated neutrophils (APC-like TAN) in which markers for both granulocytes (CD11b, CD66b, CD15) and monocytes (CD33, CD14, HLA-DR, CCR7, CD86, CD20) co-exist. This evidence concerns the gene CD86 and neoplasm.